Grants and Contributions:
Title:
2425-HQ-000003
Agreement Number:
2425-HQ-000003
Agreement Value:
$140,100,307.00
Agreement Date:
Mar 15, 2024 - Mar 31, 2027
Description:
To enhance the health of Canadians and health system sustainability by promoting the cost-effective and optimal use of drugs and other health technologies.
Organization:
Health Canada
Expected Results:
Health care decision-makers access evidence on drugs and medical devices and are equipped with the knowledge, skills and supports to incorporate evidence in decision-making.
Location:
Ottawa, Ontario, CA K1S 5S8
Reference Number:
271-2024-2025-Q2-00019
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
132633868
Recipient Type:
Other
Additional Information:
The total agreement value previously disclosed has been updated to reflect an increase resulting from this amendment.
Amendment Date
Aug 30, 2024
Recipient's Legal Name:
Canadian Agency for Drugs and Technologies in Health
Program:
Contribution to the Canadian Agency for Drugs and Technologies in Health
Program Purpose:
Canadian Health Systems and Programs
Amendments: